NICE was unable to develop medical technologies guidance on the Assurance Nasal Alar SpO2 Sensor because no evidence submission was received from the company. 27 March 2017 Discontinued. NICE was ...
Masimo Corp. is sponsoring a new clinical study titled “Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations.” The goal is to confirm ...
NICE has developed a medtech innovation briefing (MIB) on the Nasal Alar SpO2 sensor for monitoring oxygen saturation by pulse oximetry. May 2019: The Medicines and Healthcare products Regulatory ...
Covidien (NYSE: COV), a leading global supplier of healthcare products, today announced the integration of its Nellcor™ OxiMax™ oximetry system into Philips IntelliVue and M-Series patient monitors.